291 related articles for article (PubMed ID: 32706863)
1. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.
Tirosh A; Killian JK; Petersen D; Zhu YJ; Walker RL; Blau JE; Nilubol N; Patel D; Agarwal SK; Weinstein LS; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2020 Oct; 105(10):3285-94. PubMed ID: 32706863
[TBL] [Abstract][Full Text] [Related]
2. Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
Tirosh A; Mukherjee S; Lack J; Gara SK; Wang S; Quezado MM; Keutgen XM; Wu X; Cam M; Kumar S; Patel D; Nilubol N; Tyagi MV; Kebebew E
Cancer; 2019 Apr; 125(8):1247-1257. PubMed ID: 30620390
[TBL] [Abstract][Full Text] [Related]
3. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
[TBL] [Abstract][Full Text] [Related]
5. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors.
Erlic Z; Ploeckinger U; Cascon A; Hoffmann MM; von Duecker L; Winter A; Kammel G; Bacher J; Sullivan M; Isermann B; Fischer L; Raffel A; Knoefel WT; Schott M; Baumann T; Schaefer O; Keck T; Baum RP; Milos I; Muresan M; Peczkowska M; Januszewicz A; Cupisti K; Tönjes A; Fasshauer M; Langrehr J; von Wussow P; Agaimy A; Schlimok G; Lamberts R; Wiech T; Schmid KW; Weber A; Nunez M; Robledo M; Eng C; Neumann HP; ;
Endocr Relat Cancer; 2010 Dec; 17(4):875-83. PubMed ID: 20660572
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study.
Chiloiro S; Lanza F; Bianchi A; Schinzari G; Brizi MG; Giampietro A; Rufini V; Inzani F; Giordano A; Rindi G; Pontecorvi A; De Marinis L
Endocrine; 2018 May; 60(2):362-367. PubMed ID: 28567607
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors.
Nuñez JE; Donadio M; Filho DR; Rego JF; Barros M; Formiga MN; Lopez R; Riechelmann R
J Gastrointest Oncol; 2019 Aug; 10(4):645-651. PubMed ID: 31392045
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional alterations in hereditary and sporadic nonfunctioning pancreatic neuroendocrine tumors according to genotype.
Keutgen XM; Kumar S; Gara SK; Boufraqech M; Agarwal S; Hruban RH; Nilubol N; Quezado M; Finney R; Cam M; Kebebew E
Cancer; 2018 Feb; 124(3):636-647. PubMed ID: 29149451
[TBL] [Abstract][Full Text] [Related]
9. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
10. GEP- NETS UPDATE: Genetics of neuroendocrine tumors.
Crona J; Skogseid B
Eur J Endocrinol; 2016 Jun; 174(6):R275-90. PubMed ID: 27165966
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
12. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome.
Anlauf M; Schlenger R; Perren A; Bauersfeld J; Koch CA; Dralle H; Raffel A; Knoefel WT; Weihe E; Ruszniewski P; Couvelard A; Komminoth P; Heitz PU; Klöppel G
Am J Surg Pathol; 2006 May; 30(5):560-74. PubMed ID: 16699310
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
15. Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease.
Gucer H; Szentgyorgyi E; Ezzat S; Asa SL; Mete O
Virchows Arch; 2013 Oct; 463(4):593-7. PubMed ID: 23913169
[TBL] [Abstract][Full Text] [Related]
16. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
17. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.
Moore PS; Missiaglia E; Antonello D; Zamò A; Zamboni G; Corleto V; Falconi M; Scarpa A
Genes Chromosomes Cancer; 2001 Oct; 32(2):177-81. PubMed ID: 11550286
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of neuroendocrine tumors.
Duerr EM; Chung DC
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):1-14. PubMed ID: 17382262
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.
McRonald FE; Morris MR; Gentle D; Winchester L; Baban D; Ragoussis J; Clarke NW; Brown MD; Kishida T; Yao M; Latif F; Maher ER
Mol Cancer; 2009 Jun; 8():31. PubMed ID: 19493342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
